In a 32-year-old man with type 1 diabetes mellitus (HbA1c 6.6%) presenting with fever, chills, rigors, abdominal pain, nausea, vomiting, and ultrasound showing mild hepatomegaly and terminal ileum and ileocecal junction wall thickening with pericolonic fat stranding, what is the most likely cause and appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Most Likely Diagnosis: Crohn's Disease with Possible Pyogenic Liver Abscess

The most likely diagnosis is Crohn's disease (CD) presenting with terminal ileitis and ileocecal involvement, with hepatomegaly potentially representing either reactive hepatomegaly or an early pyogenic liver abscess—a rare but recognized extraintestinal manifestation of CD.

Diagnostic Reasoning

Why Crohn's Disease is the Primary Consideration

The imaging findings are highly characteristic of CD:

  • Terminal ileum mural thickening with involvement of the ileocecal junction and cecum
  • Fat stranding (pericolonic fat wrapping) is a classic inflammatory sign
  • The ileocecal region is the most common site of CD involvement (60-70% of cases)
  • Wall thickening threshold >4mm is considered abnormal 1

The clinical presentation supports this:

  • Young male (peak CD incidence 15-35 years)
  • Fever, chills, rigors indicating active inflammation
  • Abdominal pain, nausea, vomiting
  • Well-controlled T1DM (HbA1c 6.6%) makes diabetic complications less likely

The Hepatomegaly Component

The mild hepatomegaly requires careful attention. In this context, it most likely represents:

  1. Pyogenic liver abscess (PLA) - A rare but important CD complication 2. A recent 2025 case report describes a 39-year-old man with CD presenting with fever, hepatomegaly, and terminal ileum thickening with liver abscesses as the initial manifestation 2. This mirrors your patient's presentation closely.

  2. Reactive hepatomegaly from systemic inflammation

  3. Less likely: Glycogenic hepatopathy (Mauriac syndrome) is excluded given the excellent HbA1c control 3

Immediate Management Algorithm

Step 1: Confirm Diagnosis and Rule Out Complications (Emergency Phase)

Obtain contrast-enhanced CT abdomen/pelvis immediately 4:

  • CT is the first-line radiological investigation in the emergency setting for IBD patients 4
  • Sensitivity 85%, specificity 88% for detecting intra-abdominal abscesses 4
  • Essential to exclude perforation, abscess, or obstruction
  • Critical: The ultrasound findings are suggestive but insufficient—you need CT to definitively identify liver abscesses and assess for other complications 4

Laboratory workup:

  • Complete blood count (expect leukocytosis, possible anemia)
  • Inflammatory markers (CRP, ESR)
  • Liver function tests (assess for cholestatic changes)
  • Blood cultures (before antibiotics)
  • Fecal calprotectin (elevated in CD)
  • Anti-Saccharomyces cerevisiae antibodies (ASCA) - positive in 50-60% of CD 2

Step 2: Immediate Therapeutic Interventions

If liver abscess is confirmed on CT:

  1. Start broad-spectrum IV antibiotics immediately (before culture results):

    • Cover gram-negative enteric organisms and anaerobes
    • Typical regimen: Piperacillin-tazobactam 4.5g IV q6h OR ceftriaxone 2g IV daily + metronidazole 500mg IV q8h
    • Adjust based on cultures (Streptococcus intermedius was isolated in the reported case 2)

  2. Percutaneous drainage if abscess >5cm or patient remains septic despite antibiotics 2

  3. Defer immunosuppressive therapy until infection is cleared 2

If no abscess identified:

  • Proceed directly to CD-specific management (see below)

Step 3: Definitive Diagnosis of Crohn's Disease

Colonoscopy with ileoscopy and biopsies (once acute infection excluded):

  • Visualize ileocecal inflammation and ulceration
  • Obtain biopsies (may show granulomas in 30-50%, but absence doesn't exclude CD 2)
  • Document disease extent and severity

MR enterography (after acute phase):

  • Preferred technique for assessing strictures and disease activity 4
  • Differentiates inflammatory from fibrotic strictures
  • Better for preoperative planning

Step 4: Crohn's Disease Treatment Initiation

Once infection is cleared or excluded:

Induction therapy options (based on severity):

  1. Biologic therapy (preferred for moderate-severe disease with complications):

    • Ustekinumab (IL-12/23 inhibitor) - used successfully in the reported case 2
    • Anti-TNF agents (infliximab, adalimumab)
    • Consider earlier biologic use given potential abscess complication

  2. Corticosteroids (if biologics delayed):

    • Prednisone 40-60mg daily, taper over 8-12 weeks
    • For acute flare management

  3. Nutritional therapy:

    • Exclusive enteral nutrition (EEN) can be used as bridge therapy when immunosuppression contraindicated 2
    • Particularly useful if active infection present

Maintenance therapy:

  • Continue biologic agent
  • Consider adding immunomodulator (azathioprine, 6-mercaptopurine) for combination therapy
  • Monitor therapeutic drug levels

Step 5: Diabetes Management Considerations

Monitor glucose control closely:

  • Acute illness and corticosteroids will worsen glycemic control
  • Increase insulin doses by 20-50% if starting steroids
  • More frequent glucose monitoring (q4-6h initially)
  • Watch for DKA if patient becomes non-compliant due to illness

Critical Pitfalls to Avoid

  1. Don't dismiss hepatomegaly as "reactive" without CT imaging—missing a liver abscess can be fatal 2

  2. Don't start immunosuppression before excluding abscess—this was explicitly emphasized in the case report where treatment was deferred until infection cleared 2

  3. Don't assume abdominal pain is DKA-related given the excellent HbA1c—this would be a dangerous misattribution 5

  4. Don't rely on ultrasound alone—while US has 75-94% sensitivity for CD, CT is superior for abscess detection and is the guideline-recommended first-line test in acute presentations 1, 4

  5. Don't delay antibiotics if abscess suspected—blood cultures should be drawn but antibiotics started empirically

Prognosis and Follow-up

With appropriate management:

  • Liver abscesses typically resolve with 4-6 weeks of antibiotics and drainage 2
  • CD requires lifelong management with regular monitoring
  • The reported case achieved clinical remission at 3 months with weight recovery 2
  • Regular colonoscopic surveillance needed to assess mucosal healing

References

1
Guideline

acr appropriateness criteria® crohn disease.

Journal of the American College of Radiology, 2020

Related Questions

In a 59-year-old woman with severe hyperglycemia, high HbA1c, impaired renal function, hypernatremia, mild hyperkalemia, hyperchloremia, metabolic acidosis with high anion gap, high serum osmolality, concentrated urine, tachycardia, tachypnea, dehydration, and altered mental status, what is the most likely cause of her symptoms: arginine vasopressin resistance, central diabetes insipidus, hypovolemic hypernatremia, or primary polydipsia?
How should I manage an 84‑year‑old patient with diabetes mellitus and dementia who presents with eight days of diarrhea, altered mental status, hyperkalaemia, acute kidney injury, and metabolic acidosis, with a normal CT (computed tomography) head?
How should I manage a patient with abdominal pain and a blood glucose of 24.5 mmol/L (≈441 mg/dL)?
In a 50-year-old man with type 2 diabetes mellitus, recent vomiting (4–5 episodes), bilateral hypochondriac abdominal pain, and random blood glucose of 300 mg/dL, is it appropriate to give an injection of diclofenac and an injection of hyoscine butylbromide (Buscopan)?
Could a 17-month-old female presenting with polydipsia and irritability have type 1 diabetes?
Is there scientific evidence supporting the use of 100 mg aspirin for secondary prevention after an ischemic event?
How should a patient with a foreign-body sensation at the hyoid after eating pork, odynophagia, mild sialorrhea, ability to tolerate liquids, and a history of esophagitis be managed?
During which phase of treatment with GLP‑1 receptor agonists does gallstone formation occur—early (within the first few months) or later?
What are the maximum recommended nebulized doses of Pulmicort (budesonide) and Atrovent (ipratropium bromide)?
What management options are available for a patient taking sertraline and bupropion who is experiencing inattention?
What is the association between nephrotic syndrome and carpal tunnel syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.